Santen Pharmaceutical Valuation

SNPHY Stock  USD 9.41  0.18  1.95%   
At this time, the company appears to be fairly valued. Santen Pharmaceutical has a current Real Value of $9.68 per share. The regular price of the company is $9.41. Our model measures the value of Santen Pharmaceutical from inspecting the company fundamentals such as Operating Margin of (0) %, shares outstanding of 388.22 M, and Return On Equity of -0.0264 as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Fairly Valued
Today
9.41
Please note that Santen Pharmaceutical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Santen Pharmaceutical is based on 3 months time horizon. Increasing Santen Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Santen Pharmaceutical Co is useful when determining the fair value of the Santen pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Santen Pharmaceutical. Since Santen Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Santen Pink Sheet. However, Santen Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  9.41 Real  9.68 Hype  9.41
The real value of Santen Pink Sheet, also known as its intrinsic value, is the underlying worth of Santen Pharmaceutical Company, which is reflected in its stock price. It is based on Santen Pharmaceutical's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Santen Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Santen Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
9.68
Real Value
12.27
Upside
Estimating the potential upside or downside of Santen Pharmaceutical Co helps investors to forecast how Santen pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Santen Pharmaceutical more accurately as focusing exclusively on Santen Pharmaceutical's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
6.829.4112.00
Details

Santen Pharmaceutical Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Santen Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Santen Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Santen Pharmaceutical competition to find correlations between indicators driving Santen Pharmaceutical's intrinsic value. More Info.
Santen Pharmaceutical Co is currently regarded as top stock in price to earning category among related companies. It is currently regarded as top stock in price to book category among related companies fabricating about  0.10  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Santen Pharmaceutical Co is roughly  10.23 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Santen Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Santen Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Santen Pharmaceutical's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Santen Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Santen Pharmaceutical and how it compares across the competition.

About Santen Pharmaceutical Valuation

The pink sheet valuation mechanism determines the current worth of Santen Pharmaceutical Co on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Santen Pharmaceutical Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Santen Pharmaceutical based exclusively on its fundamental and basic technical indicators. By analyzing Santen Pharmaceutical's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Santen Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Santen Pharmaceutical. We calculate exposure to Santen Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Santen Pharmaceutical's related companies.
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan. Santen Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 4315 people.

8 Steps to conduct Santen Pharmaceutical's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Santen Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Santen Pharmaceutical's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Santen Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Santen Pharmaceutical's revenue streams: Identify Santen Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Santen Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Santen Pharmaceutical's growth potential: Evaluate Santen Pharmaceutical's management, business model, and growth potential.
  • Determine Santen Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Santen Pharmaceutical's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Santen Pharmaceutical Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Santen Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding400.4 M
Quarterly Earnings Growth Y O Y0.232
Forward Price Earnings12.9199
Retained Earnings290.5 B
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Santen Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Santen Pink Sheet analysis

When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Please note, there is a significant difference between Santen Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Santen Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Santen Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.